Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | GABRP | O00591 | 1/20 | 0.41 |
| ▸ | GABRD | O14764 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.41 |
| ▸ | GABRE | P78334 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.41 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.41 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.41 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL5722383 | 0.98 | TSHR (0.42) | CES2CES1TSHRGABRPGABRD | |
| Trifluoroacetic Acid SCHEMBL6256275 | 0.87 | LMNA (0.46) | TSHRGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL242069 | 0.84 | CES2 (0.61) | CES2CES1TSHRGABRPGABRD | |
| SCHEMBL304519 | 0.84 | CES2 (0.61) | CES2CES1TSHRGABRPGABRD | |
| SCHEMBL1260777 | 0.84 | CES2 (0.61) | CES2CES1TSHRGABRPGABRD | |
| SCHEMBL25212375 | 0.84 | CES2 (0.61) | CES2CES1TSHRGABRPGABRD | |
| SCHEMBL1873055 | 0.84 | CES2 (0.61) | CES2CES1TSHRGABRPGABRD | |
| SCHEMBL11964239 | 0.84 | CES2 (0.61) | CES2CES1TSHRGABRPGABRD | |
| SCHEMBL1072831 | 0.84 | CES2 (0.61) | CES2CES1TSHRGABRPGABRD | |
| SCHEMBL11964237 | 0.84 | CES2 (0.61) | CES2CES1TSHRGABRPGABRD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109111451-B | Dihydropyrimidine compound and application thereof in medicine | 广东东阳光药业有限公司 | 2020-08-11 | — | — | CN | disclosed |
| EP-3658554-A1 | DIHYDROPYRIMIDINE COMPOUNDS AND USES THEREOF IN MEDICINE | North & South Brother Pharmacy Investment Company Limited (CN) | 2020-06-03 | — | — | EP | disclosed |
| WO-2019001396-A1 | DIHYDROPYRIMIDINE COMPOUNDS AND USES THEREOF IN MEDICINE | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2019-01-03 | — | — | WO | disclosed |
| CN-104066730-B | Heterocyclic compounds and their use as type III receptor tyrosine kinase modulators | 埃姆比特生物科学公司 | 2017-03-08 | — | — | CN | disclosed |
| CN-101506185-B | Oxolane is [3,2-B] pyrroles-3-ketone intermediate also | 格兰泰有限公司 | 2016-06-29 | — | — | CN | disclosed |
| CN-101528731-B | Aminopyridine derivatives having AuroraA selective inhibitory action | MSD KK | 2014-05-07 | — | — | CN | disclosed |
| CN-101511841-B | Tetrahydrofuro [3,2-B ] pyrrol-3-ones as cathepsin K inhibitors | AMURA THERAPEUTICS LTD | 2013-08-07 | — | — | CN | disclosed |
| CN-102127078-A | Heterocyclic janus kinase 3 inhibitors | ASTELLAS PHARMA INC | 2011-07-20 | — | — | CN | disclosed |
| EP-2297162-A1 | COMPOUNDS | Amura Therapeutics Limited (GB) | 2011-03-23 | — | — | EP | disclosed |
| WO-2009112839-A1 | COMPOUNDS | AMURA THERAPEUTICS LIMITED (GB) | 2009-09-17 | — | — | WO | disclosed |
| CN-101528731-A | Novel aminopyridine derivatives having AuroraA selective inhibitory action | BANYU PHARMA CO LTD (JP) | 2009-09-09 | — | — | CN | disclosed |
| CN-101511841-A | Tetrahydrofuro [3, 2-B ] pyrrol-3-ones as cathepsin K inhibitors | ARMURA THERAPEUTICS LTD (GB) | 2009-08-19 | — | — | CN | disclosed |
| CN-101506185-A | Tetrahydrofuro [3, 2-B] pyrrol-3-one intermediates | ARMURA THERAPEUTICS LTD (GB) | 2009-08-12 | — | — | CN | disclosed |
| CN-101223168-A | Heterocyclic JANUS kinase 3 inhibitors | ASTELLAS PHARMA INC (JP) | 2008-07-16 | — | — | CN | disclosed |
| EP-1358183-A2 | CYSTEINE PROTEASE INHIBITORS | MEDIVIR AB (SE) | 2003-11-05 | — | — | EP | disclosed |
| WO-2002088106-A2 | CYSTEINE PROTEASE INHIBITORS | MEDIVIR AB (SE) | 2002-11-07 | — | — | WO | disclosed |
| WO-1994013693-A1 | NOVEL INHIBITORS OF FACTOR Xa | CORVAS INTERNATIONAL, INC. (US) | 1994-06-23 | — | — | WO | disclosed |
| WO-1993015756-A1 | INHIBITORS OF THROMBOSIS | CORVAS INTERNATIONAL, INC. (US) | 1993-08-19 | — | — | WO | disclosed |